Hypoxia-inducible factor-1alpha protects the liver against ischemia-reperfusion injury by regulating the A2B adenosine receptor

References

• Zhai Y, Petrowsky H, Hong JC, et al. Ischaemia–reperfusion injury in liver transplantation—from bench to bedside. Nat Rev Gastroenterol Hepatol. 2013;10(2):79–89.
   PubMed Web of Science ®Google Scholar
• Peralta C, Jiménez-Castro MB, Gracia-Sancho J. Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J Hepatol. 2013;59(5):1094–1106.
   PubMed Web of Science ®Google Scholar
• Adelmann D, Roll GR, Kothari R, et al. The impact of deceased donor liver extraction time on early allograft function in adult liver transplant recipients. Transplantation. 2018;102(11):e466–e71. .
   PubMed Web of Science ®Google Scholar
• Maheshwari A, Maley W, Li Z, et al. Biliary complications and outcomes of liver transplantation from donors after cardiac death. Liver Transpl. 2007;13(12):1645–1653.
   PubMed Web of Science ®Google Scholar
• Jaeschke H, Woolbright BL. Current strategies to minimize hepatic ischemia–reperfusion injury by targeting reactive oxygen species. Transplant Rev (Orlando). 2012;26(2):103–114.
   PubMedGoogle Scholar
• Semenza GL. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE. 2007;2007(407):cm8.
   PubMedGoogle Scholar
• Slemc L, Kunej T. Transcription factor HIF1A: downstream targets, associated pathways, polymorphic hypoxia response element (HRE) sites, and initiative for standardization of reporting in scientific literature. Tumour Biol. 2016;37(11):14851–14861.
   PubMedGoogle Scholar
• Corrado C, Fontana S. Hypoxia and HIF Signaling: One Axis with Divergent Effects. Int J Mol Sci. 2020; 21(16):5611
   PubMed Web of Science ®Google Scholar
• Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3(10):721–732.
   PubMed Web of Science ®Google Scholar
• Plock J, Frese S, Keogh A, et al. Activation of non-ischemic, hypoxia-inducible signalling pathways up-regulate cytoprotective genes in the murine liver. J Hepatol. 2007;47(4):538–545. .
   PubMed Web of Science ®Google Scholar
• Abe Y, Uchinami H, Kudoh K, et al. Liver epithelial cells proliferate under hypoxia and protect the liver from ischemic injury via expression of HIF-1 alpha target genes. Surgery. 2012;152(5):869–878.
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu Z, Xiao Q, et al. Donor treatment with a hypoxia-inducible factor-1 agonist prevents donation after cardiac death liver graft injury in a rat isolated perfusion model. Artif Organs. 2018;42(3):280–289.
   PubMed Web of Science ®Google Scholar
• Burnstock G. Purinergic signalling: therapeutic developments. Front Pharmacol. 2017;8:661.
   PubMed Web of Science ®Google Scholar
• Dou L, Chen YF, Cowan PJ, et al. Extracellular ATP signaling and clinical relevance. Clin Immunol. 2018;188:67–73.
   PubMed Web of Science ®Google Scholar
• Smith K. Transplantation: ADORA2B helps to block liver injury. Nat Rev Gastroenterol Hepatol. 2013;10(8):444.
   PubMedGoogle Scholar
• Aherne CM, Kewley EM, Eltzschig HK. The resurgence of A2B adenosine receptor signaling. Biochim Biophys Acta. 2011;1808(5):1329–1339.
   PubMed Web of Science ®Google Scholar
• Eltzschig HK, Sitkovsky MV, Robson SC. Purinergic signaling during inflammation. N Engl J Med. 2012;367(24):2322–2333.
   PubMed Web of Science ®Google Scholar
• Zimmerman MA, Grenz A, Tak E, et al. Signaling through hepatocellular A2B adenosine receptors dampens ischemia and reperfusion injury of the liver. Proc Natl Acad Sci U S A. 2013;110(29):12012–12017.
   PubMed Web of Science ®Google Scholar
• Kong T, Westerman KA, Faigle M, et al. HIF-dependent induction of adenosine A2B receptor in hypoxia. The FASEB Journal. 2006;20(13):2242–2250.
   PubMed Web of Science ®Google Scholar
• Yang M, Ma C, Liu S, et al. HIF-dependent induction of adenosine receptor A2b skews human dendritic cells to a Th2-stimulating phenotype under hypoxia. Immunol Cell Biol. 2010;88(2):165–171.
   PubMed Web of Science ®Google Scholar
• Eckle T, Kewley EM, Brodsky KS, et al. Identification of hypoxia-inducible factor HIF-1A as transcriptional regulator of the A2B adenosine receptor during acute lung injury. J Immunol. 2014;192(3):1249–1256. .
   PubMed Web of Science ®Google Scholar
• Kwon JH, Lee J, Kim J, et al. HIF-1α regulates A2B adenosine receptor expression in liver cancer cells. Exp Ther Med. 2019;18:4231–4240.
   PubMed Web of Science ®Google Scholar
• Lan J, Lu H, Samanta D, et al. Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment. Proc Natl Acad Sci U S A. 2018;115(41):E9640–e8.
   PubMed Web of Science ®Google Scholar
• Liu Z, Lai CH, Zhang X, et al. Simvastatin ameliorates total liver ischemia/reperfusion injury via KLF2-mediated mechanism in rats. Clin Res Hepatol Gastroenterol. 2019;43(2):171–178.
   PubMed Web of Science ®Google Scholar
• Hoppe G, Yoon S, Gopalan B, et al. Comparative systems pharmacology of HIF stabilization in the prevention of retinopathy of prematurity. Proc Natl Acad Sci U S A. 2016;113(18):E2516–25. .
   PubMed Web of Science ®Google Scholar
• Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, et al. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation. 1993;55(6):1265–1271.
   Web of Science ®Google Scholar
• Peyssonnaux C, Datta V, Cramer T, et al. HIF-1α expression regulates the bactericidal capacity of phagocytes. J Clin Invest. 2005;115(7):1806–1815. .
   PubMed Web of Science ®Google Scholar
• Deng J, Huang Q, Wang Y, et al. Hypoxia-inducible factor-1alpha regulates autophagy to activate hepatic stellate cells. Biochem Biophys Res Commun. 2014;454(2):328–334.
   PubMed Web of Science ®Google Scholar
• Brocato J, Chervona Y, Costa M. Molecular responses to Hypoxia-inducible factor 1α and beyond. Mol Pharmacol. 2014;85(5):651–657.
   PubMed Web of Science ®Google Scholar
• Li J, Tao T, Xu J, et al. HIF‑1α attenuates neuronal apoptosis by upregulating EPO expression following cerebral ischemia‑reperfusion injury in a rat MCAO model. Int J Mol Med. 2020;45:1027–1036.
   PubMed Web of Science ®Google Scholar
• Ong SG, Lee WH, Theodorou L, et al. HIF-1 reduces ischaemia–reperfusion injury in the heart by targeting the mitochondrial permeability transition pore. Cardiovasc Res. 2014;104(1):24–36.
   PubMed Web of Science ®Google Scholar
• Zhao X, Jin Y, Li H, et al. Hypoxia-inducible factor 1 alpha contributes to pulmonary vascular dysfunction in lung ischemia-reperfusion injury. Int J Clin Exp Pathol. 2014;7:3081–3088.
   PubMed Web of Science ®Google Scholar
• Li Y, Tong L, Zhang J, et al. Galangin alleviates liver ischemia-reperfusion injury in a rat model by mediating the PI3K/AKT Pathway. Cell Physiol Biochem. 2018;51(3):1354–1363.
   PubMedGoogle Scholar
• Romero FJ, Bosch-Morell F, Romero MJ, et al. Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect. 1998;106(Suppl 5):1229–1234.
   PubMed Web of Science ®Google Scholar
• Semenza GL. Hypoxia-inducible factor 1 and cardiovascular disease. Annu Rev Physiol. 2014;76(1):39–56.
   PubMedGoogle Scholar
• Li HS, Zhou YN, Li L, et al. HIF-1α protects against oxidative stress by directly targeting mitochondria. Redox Biol. 2019;25:101109.
   PubMed Web of Science ®Google Scholar
• Vardanian AJ, Busuttil RW, Kupiec-Weglinski JW. Molecular mediators of liver ischemia and reperfusion injury: a brief review. Mol Med. 2008;14(5–6):337–345.
   PubMed Web of Science ®Google Scholar
• Huang HF, Zeng Z, Wang KH, et al. Heme oxygenase-1 protects rat liver against warm ischemia/reperfusion injury via TLR2/TLR4-triggered signaling pathways. World J Gastroenterol. 2015;21(10):2937–2948.
   PubMed Web of Science ®Google Scholar
• Gale DP, Maxwell PH. The role of HIF in immunity. Int J Biochem Cell Biol. 2010;42(4):486–494.
   PubMed Web of Science ®Google Scholar
• Cramer T, Yamanishi Y, Clausen BE, et al. HIF-1α is essential for myeloid cell-mediated inflammation. Cell. 2003;112(5):645–657.
   PubMed Web of Science ®Google Scholar
• Feinman R, Deitch EA, Watkins AC, et al. HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol. 2010;299(4):G833–43.
   PubMed Web of Science ®Google Scholar
• Furuta GT, Turner JR, Taylor CT, et al. Hypoxia-inducible factor 1–dependent induction of intestinal trefoil factor protects barrier function during Hypoxia. J Exp Med. 2001;193(9):1027–1034.
   PubMed Web of Science ®Google Scholar
• Jin S, Dai CL. Attenuation of reperfusion-induced hepatocyte apoptosis is associated with reversed bcl-2/bax ratio in hemi-hepatic artery-preserved portal occlusion. J Surg Res. 2012;174(2):298–304.
   PubMed Web of Science ®Google Scholar
• Liu W, Miao Y, Zhang L, et al. MiR-211 protects cerebral ischemia/reperfusion injury by inhibiting cell apoptosis. Bioengineered. 2020;11(1):189–200.
   PubMed Web of Science ®Google Scholar
• Eefting F, Rensing B, Wigman J, et al. Role of apoptosis in reperfusion injury. Cardiovasc Res. 2004;61(3):414–426. .
   PubMed Web of Science ®Google Scholar
• Volm M, Koomägi R. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res. 2000;20:1527–1533.
   PubMed Web of Science ®Google Scholar
• Eckle T, Hartmann K, Bonney S, et al. Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat Med. 2012;18(5):774–782.
   PubMed Web of Science ®Google Scholar
• Hart ML, Jacobi B, Schittenhelm J, et al. Cutting Edge: A2B Adenosine receptor signaling provides potent protection during intestinal ischemia/reperfusion injury. J Immunol. 2009;182(7):3965–3968.
   PubMed Web of Science ®Google Scholar
• Grenz A, Osswald H, Eckle T, et al. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med. 2008;5(6):e137.
   PubMed Web of Science ®Google Scholar
• Granja TF, Köhler D, Schad J, et al. Adenosine receptor Adora2b plays a mechanistic role in the protective effect of the volatile anesthetic sevoflurane during liver ischemia/reperfusion. Anesthesiology. 2016;125(3):547–560.
   PubMed Web of Science ®Google Scholar